Among a few bioavailability enhancing technologies available today, the amorphous dispersion technology is a growing approach to improve solubility and in-vitro dissolution, and hence, the bioavailability of these solubility-limited compounds. This webinar introduces key spray dried dispersion (SDD) development considerations to allow for identification of a stable prototype that will enhance and sustain in-vivo drug solubility.